Michael Greiner - 13 May 2025 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
Former Interim CEO
Signature
/s/ Mojirade James, as attorney-in-fact for Michael C. Greiner
Issuer symbol
AVNS
Transactions as of
13 May 2025
Transactions value $
-$301,365
Form type
4
Filing time
14 May 2025, 14:28:49 UTC
Previous filing
11 Mar 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Greiner Michael Former Interim CEO 5405 WINDWARD PKWY, ALPHARETTA /s/ Mojirade James, as attorney-in-fact for Michael C. Greiner 14 May 2025 0001520392

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Tax liability -$246K -19.8K -8.82% $12.43 204K 13 May 2025 Direct F1
transaction AVNS Common Stock Tax liability -$55.6K -4.47K -2.19% $12.43 200K 13 May 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 44,189 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on October 29, 2024 and (ii) vested on May 13, 2025. Each TRSU is the economic equivalent of one share of Common Stock.
F2 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 10,000 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on December 3, 2024 and (ii) vested on May 13, 2025. Each TRSU is the economic equivalent of one share of Common Stock.